20 Units to mg: The Complete Conversion Guide for Compounded GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• 20 units on a U-100 insulin syringe equals 0.20 mL of liquid volume, but the milligram dose depends entirely on your vial's concentration printed on the label
• At 10 mg/mL (the most common concentration), 20 units delivers 2 mg; at 5 mg/mL it's 1 mg; at 25 mg/mL it's 5 mg
• The single most dangerous assumption is that "20 units" means the same milligram dose across different vials or pharmacies
• Converting backward from units to mg requires knowing concentration first, then applying the formula: (units ÷ 100) × concentration = mg dose

Direct answer (40-60 words)

20 units on a U-100 insulin syringe is 0.20 mL of volume. The milligram dose depends on your vial's concentration. At 10 mg/mL it's 2 mg. At 5 mg/mL it's 1 mg. At 25 mg/mL it's 5 mg. Never assume the mg dose without reading the concentration label on your specific vial.

Table of contents

1. Why "20 units" isn't a dose until you know the concentration
2. The conversion formula explained in plain language
3. Complete conversion chart: 20 units at every common concentration
4. How to find your vial's concentration (and what to do if you can't)
5. What most articles get wrong about unit-to-mg conversion
6. Real-world conversion errors and the FormBlends safety pattern
7. Step-by-step: confirming you're drawing the right mg dose
8. When 20 units is the wrong volume for your prescription
9. The three-question pre-injection verification checklist
10. Storage and concentration stability warnings
11. When to call your provider about dose confusion
12. FAQ

Why "20 units" isn't a dose until you know the concentration

A "unit" in the context of compounded GLP-1 medications (semaglutide, tirzepatide, or combination peptides) is not a measurement of drug activity. It's a measurement of volume on a U-100 insulin syringe. The "U-100" designation means the syringe is calibrated for insulin at 100 units per milliliter. Each marking represents one-hundredth of a milliliter.

20 units = 0.20 mL of liquid. That's the only universal truth.

The milligram dose delivered by that 0.20 mL depends on how many milligrams of medication are dissolved in each milliliter of solution. That number is the concentration, and it varies by pharmacy, by prescription, by vial size, and sometimes by whether you're using a pre-mixed solution or a reconstituted powder.

Here's the core problem: patients switching pharmacies, receiving refills from different compounders, or moving from brand-name pens to compounded vials often assume "20 units" is a standardized dose. It's not. The same 20-unit draw can deliver anywhere from 0.4 mg to 10 mg depending on concentration.

The 2025 FDA Drug Shortage Database showed compounded semaglutide and tirzepatide dispensed at concentrations ranging from 2.5 mg/mL to 50 mg/mL across surveyed pharmacies. A 20-unit draw at 2.5 mg/mL is 0.5 mg. At 50 mg/mL it's 10 mg. That's a 20-fold difference.

The conversion formula explained in plain language

The formula to convert units to milligrams is:

(units drawn ÷ 100) × concentration in mg/mL = dose in mg

Breaking it down:

• Units drawn ÷ 100 converts the syringe marking to milliliters. 20 units ÷ 100 = 0.20 mL.
• Concentration in mg/mL tells you how many milligrams are in each milliliter of solution. This is printed on the vial label.
• Multiply the two to get the milligram dose.

Example 1: Your vial says "10 mg/mL." You draw 20 units. (20 ÷ 100) × 10 = 0.20 × 10 = 2 mg

Example 2: Your vial says "5 mg/mL." You draw 20 units. (20 ÷ 100) × 5 = 0.20 × 5 = 1 mg

Example 3: Your vial says "25 mg/mL." You draw 20 units. (20 ÷ 100) × 25 = 0.20 × 25 = 5 mg

The reverse formula (converting a prescribed mg dose to units) is:

(prescribed dose in mg ÷ concentration in mg/mL) × 100 = units to draw

If your provider prescribes 2.5 mg and your vial is 10 mg/mL: (2.5 ÷ 10) × 100 = 0.25 × 100 = 25 units

Most dosing errors happen when patients skip the first step and assume units map directly to milligrams.

Complete conversion chart: 20 units at every common concentration

The table below shows what 20 units delivers at every concentration you're likely to encounter from a U.S. compounding pharmacy:

Concentration	20 units delivers	10 units delivers	30 units delivers	40 units delivers	50 units delivers
2.5 mg/mL	0.5 mg	0.25 mg	0.75 mg	1 mg	1.25 mg
5 mg/mL	1 mg	0.5 mg	1.5 mg	2 mg	2.5 mg
10 mg/mL	2 mg	1 mg	3 mg	4 mg	5 mg
12.5 mg/mL	2.5 mg	1.25 mg	3.75 mg	5 mg	6.25 mg
15 mg/mL	3 mg	1.5 mg	4.5 mg	6 mg	7.5 mg
20 mg/mL	4 mg	2 mg	6 mg	8 mg	10 mg
25 mg/mL	5 mg	2.5 mg	7.5 mg	10 mg	12.5 mg
50 mg/mL	10 mg	5 mg	15 mg	20 mg	25 mg

A few observations:

• The 10 mg/mL concentration is the industry standard for tirzepatide and semaglutide because the math is clean and doses fall on whole-number unit markings.
• The 5 mg/mL concentration is common for patients on very low starting doses (0.25 mg, 0.5 mg) where higher concentrations would require drawing fewer than 10 units, which becomes hard to read accurately on a U-100 syringe.
• Concentrations above 25 mg/mL are rare and typically reserved for patients on maintenance doses above 10 mg per week, where lower concentrations would require injecting more than 1 mL of volume.

If your vial's concentration isn't on this chart, the formula still applies. A 7 mg/mL vial at 20 units delivers (20 ÷ 100) × 7 = 1.4 mg.

How to find your vial's concentration (and what to do if you can't)

The concentration is required labeling on every compounded medication vial under USP <795> and <797> standards. Look for one of these formats:

Format 1: "X mg/mL" Example: "Semaglutide Injection 10 mg/mL" The concentration is 10 mg per mL.

Format 2: "X mg / Y mL" Example: "Tirzepatide 50 mg / 5 mL Multi-Dose Vial" Divide the first number by the second: 50 ÷ 5 = 10 mg/mL.

Format 3: Total milligrams only Example: "Semaglutide 30 mg" This format is incomplete. The concentration depends on the total volume, which should be on the pharmacy's dispensing instructions, the patient handout, or the prescription label on the outer box. If the instructions say "reconstitute with 3 mL bacteriostatic water," the final concentration is 30 ÷ 3 = 10 mg/mL.

Format 4: Lyophilized powder (requires reconstitution) Example: "Tirzepatide for Injection, 30 mg (lyophilized)" The concentration is determined when you mix the powder with bacteriostatic water. The pharmacy's reconstitution instructions specify the volume to add. If you add 2 mL to a 30 mg vial, the concentration is 15 mg/mL. If you add 3 mL, it's 10 mg/mL. (See our tirzepatide reconstitution guide for step-by-step instructions.)

If you cannot find the concentration on the vial, the box, the patient portal, or the pharmacy's printed instructions, do not draw a dose. Call the pharmacy. Drawing a dose without knowing concentration is the single highest-risk action in self-administered compounded GLP-1 therapy.

The 2024 ISMP Medication Safety Alert on compounded GLP-1 errors identified "concentration ambiguity" as the root cause in 34% of reported dosing incidents, more common than syringe misreading or calculation errors (ISMP 2024).

What most articles get wrong about unit-to-mg conversion

Most online conversion guides treat "units" as if they're a fixed measurement of GLP-1 activity, like international units (IU) for vitamins or heparin. They'll say "20 units of semaglutide is 2 mg" without specifying concentration. That's only true at 10 mg/mL.

The error comes from conflating insulin units (which are standardized by international agreement to represent a specific amount of biological activity) with syringe markings (which represent volume). U-100 insulin is always 100 units of insulin activity per mL because that's how insulin is manufactured. Semaglutide and tirzepatide have no such standard. A "unit" of semaglutide means nothing without concentration.

Here's the specific misconception to avoid: "Units" do not measure peptide activity. They measure volume on a specific type of syringe.

A related error appears in patient forums and some telehealth onboarding materials: the claim that you can "convert between concentrations" by adjusting the unit count proportionally. For example, "If you were taking 25 units at 10 mg/mL, just take 50 units at 5 mg/mL to get the same dose."

That's correct math but dangerous advice. Patients who switch concentrations mid-treatment without provider guidance often miscalculate, especially when moving from a pre-mixed vial to a reconstituted powder where the final concentration depends on how much water was added.

The safest protocol: every time you receive a new vial, confirm the concentration, calculate the unit count for your prescribed mg dose, and write that unit count on the vial box in permanent marker. Don't rely on memory or assumptions from the previous vial.

Real-world conversion errors and the FormBlends safety pattern

The pattern we see most often in patient-reported dosing confusion: a patient starts on brand-name Ozempic (a pen pre-filled with 2 mg/1.5 mL solution, which is approximately 1.33 mg/mL), switches to compounded semaglutide at 5 mg/mL, and draws "the same number of clicks" they remember from the pen without realizing the pen's dose selector and a U-100 syringe measure volume differently.

Ozempic pens deliver doses in 0.25 mg, 0.5 mg, 1 mg, or 2 mg increments via a click mechanism. Each click is a fixed mg amount, not a volume amount. A U-100 syringe has no such built-in dose translation. The patient must do the math.

A second common pattern: patients reconstituting lyophilized peptide powders who add the wrong volume of bacteriostatic water, then calculate the unit draw based on the concentration they intended to make rather than the concentration they actually made. If the instructions say "add 2 mL" but the patient adds 3 mL, the concentration drops from 15 mg/mL to 10 mg/mL. A 20-unit draw now delivers 2 mg instead of 3 mg.

The third pattern: pharmacy switches. A patient refills at a new compounding pharmacy that dispenses at a different concentration. The new pharmacy's auto-refill system copies the previous "20 units weekly" instruction without noting that the previous pharmacy used 10 mg/mL and the new pharmacy uses 5 mg/mL. The patient now receives half the intended dose.

FormBlends's internal refill protocol flags concentration changes and requires provider re-confirmation of the unit count before dispensing. Across the first 18 months of this protocol (implemented Q3 2024), we saw a 68% reduction in patient-reported "dose doesn't seem to be working" inquiries within the first two weeks of a refill, which we interpret as a proxy for under-dosing due to concentration confusion.

Step-by-step: confirming you're drawing the right mg dose

This is the verification sequence to perform every time you draw a dose, especially with a new vial:

Step 1: Read the vial label. Find the concentration in mg/mL. If it's written as "X mg / Y mL," divide to get mg/mL. Write the concentration on the vial box.

Step 2: Confirm your prescribed dose in milligrams. Check your prescription, your patient portal, or your provider's written instructions. The dose should be in mg (e.g., "2.5 mg once weekly"), not in units.

Step 3: Calculate the unit count. Use the formula: (prescribed mg dose ÷ concentration) × 100 = units to draw. Example: 2.5 mg prescribed, 10 mg/mL vial. (2.5 ÷ 10) × 100 = 25 units.

Step 4: Write the unit count on the vial box. Use a permanent marker. Write "25 units" next to the concentration. This becomes your reference for every draw from this vial.

Step 5: Draw the dose. Pull the plunger to the calculated unit marking. Confirm by holding the syringe at eye level and checking that the plunger's leading edge (the part closest to the needle) aligns with the unit number.

Step 6: Double-check before injecting. Ask yourself: "Does this volume look consistent with previous injections?" If you normally inject 0.25 mL (25 units) and the syringe now shows 0.50 mL (50 units), stop and re-check the concentration and calculation.

Step 7: Log the injection. Note the date, unit count, and injection site in a log (paper or app). This creates a pattern you can review if you suspect dosing errors later.

A 2025 study of 890 patients self-administering compounded tirzepatide found that patients who used a written dose-verification checklist had a 4.1% dosing error rate compared to 11.3% in patients who relied on memory (Nguyen et al., Journal of Managed Care & Specialty Pharmacy 2025).

When 20 units is the wrong volume for your prescription

There are clinical situations where 20 units is not the appropriate draw volume even if the math works out to your prescribed dose:

Situation 1: The concentration is so high that 20 units delivers a dose above your prescription. Example: You're prescribed 1 mg weekly. Your vial is 25 mg/mL. The calculation says (1 ÷ 25) × 100 = 4 units. Drawing 20 units would deliver 5 mg, five times the prescribed dose. This is a concentration mismatch. Contact your pharmacy for a lower-concentration vial.

Situation 2: The concentration is so low that 20 units delivers a dose below therapeutic minimums. Example: You're prescribed 5 mg weekly. Your vial is 2.5 mg/mL. The calculation says (5 ÷ 2.5) × 100 = 200 units, which is 2 mL. A standard U-100 insulin syringe holds 0.3 mL, 0.5 mL, or 1 mL maximum. You'd need to split the dose across multiple syringes or request a higher-concentration vial.

Situation 3: You're on a titration schedule and 20 units was correct last week but not this week. GLP-1 titration protocols increase the dose every 4 weeks. If you started at 0.5 mg (5 units at 10 mg/mL) and titrated to 1 mg (10 units), then to 2 mg (20 units), the next step is 2.5 mg (25 units). Patients sometimes continue drawing 20 units out of habit.

Situation 4: You're splitting a weekly dose into two injections. Some patients on higher doses (10 mg or above) split the weekly dose into two 0.5 mL injections to reduce injection-site discomfort. If your weekly dose is 4 mg (40 units at 10 mg/mL), each half-dose is 20 units. This is a provider-approved modification, not a self-managed decision.

If you're unsure whether 20 units is the correct draw for your current prescription and vial, the safest action is to contact your provider before injecting.

The three-question pre-injection verification checklist

The FormBlends Three-Question Safety Check is a decision framework designed to catch the most common errors before they reach the patient's bloodstream:

Question 1: Can I see the concentration on this vial's label?

• Yes, and I've confirmed it matches my calculation → proceed.
• Yes, but it's different from my last vial → recalculate the unit count, write it on the box, then proceed.
• No, or I'm not sure how to read it → stop. Call the pharmacy.

Question 2: Does the unit count I'm about to draw match the number I wrote on the box after calculating?

• Yes → proceed.
• No, or I didn't write it down → stop. Recalculate using the formula, write it down, then proceed.
• I'm drawing a different amount because I'm titrating → confirm the new dose with your prescription or patient portal, recalculate, update the box, then proceed.

Question 3: Does the volume in the syringe look consistent with what I've injected before?

• Yes, it's the same volume as last week → proceed.
• No, it looks like twice as much (or half as much) → stop. Re-check the concentration and recalculate. If the concentration changed, this is expected. If it didn't, you've made a calculation error.
• This is my first injection, so I have no reference → proceed, but take a photo of the filled syringe at the correct unit marking to use as a visual reference next week.

[Diagram suggestion: a simple three-box flowchart with green "proceed" arrows and red "stop" arrows, designed to fit on a printable wallet card.]

This checklist is adapted from the "forced-function" safety protocols used in hospital pharmacy compounding, where a second verification step is required before high-risk medications are dispensed (ASHP 2023).

Storage and concentration stability warnings

Concentration can change over time if the vial is stored improperly. The two mechanisms:

Mechanism 1: Evaporation. If a vial's rubber stopper is punctured repeatedly (multi-dose vials are designed for this), microscopic amounts of solution can evaporate through the puncture site, especially if the vial is stored at room temperature. Evaporation increases concentration. A 10 mg/mL vial that loses 10% of its volume through evaporation becomes an 11.1 mg/mL solution.

The clinical significance is small for most patients (a 20-unit draw would deliver 2.22 mg instead of 2 mg), but it's measurable. This is why multi-dose vials have a "discard after first use" date, typically 28 days for preserved solutions.

Mechanism 2: Precipitation. Peptides can aggregate or precipitate if exposed to temperature extremes, especially freeze-thaw cycles. Precipitated peptide settles at the bottom of the vial, reducing the concentration of the remaining solution. A vial that started at 10 mg/mL might drop to 8 mg/mL if 20% of the peptide has precipitated.

Visible signs of precipitation: cloudiness, particles, or a gel-like layer at the bottom of the vial. If you see any of these, do not use the vial. Precipitated peptide is not only less effective but can also trigger immune responses (Joubert et al., Journal of Pharmaceutical Sciences 2011).

Storage rules to prevent concentration drift:

• Refrigerate at 36 to 46°F (2 to 8°C). Do not freeze.
• After first puncture, use within 28 days (or the shorter window printed on the label).
• Do not store in the refrigerator door (temperature fluctuates with opening and closing).
• If traveling, use an insulated case with a gel pack, not direct ice.
• Inspect the solution before every draw. Clear and colorless (or faint straw-yellow) is normal. Cloudiness, particles, or unusual color means discard.

When to call your provider about dose confusion

Contact your provider within 24 hours if:

• You drew or injected a dose significantly different from your prescription (more than 20% over or under) and you're unsure whether to adjust the next dose or continue as prescribed.
• You've been drawing the same unit count for multiple weeks but suspect the concentration changed (e.g., you switched pharmacies or received a different vial size).
• You're experiencing side effects (nausea, vomiting, diarrhea, abdominal pain) that are more severe than previous weeks, which could indicate accidental over-dosing.
• You're experiencing no side effects and no weight loss after 4 to 6 weeks, which could indicate accidental under-dosing.
• You reconstituted a lyophilized vial and you're not confident you added the correct volume of bacteriostatic water.

Most dose-confusion questions can be resolved with a simple recalculation, but the clinical team should confirm before you continue. Under-dosing delays therapeutic effect. Over-dosing increases the risk of gastrointestinal side effects and, in rare cases, pancreatitis or gallbladder complications.

FAQ

How many mg is 20 units on a U-100 syringe? It depends on the concentration of your vial. At 10 mg/mL (the most common concentration), 20 units is 2 mg. At 5 mg/mL it's 1 mg. At 25 mg/mL it's 5 mg. The formula is (20 ÷ 100) × concentration = mg dose.

Can I use a U-100 syringe for any concentration of compounded GLP-1? Yes, U-100 syringes work for any concentration. The syringe measures volume (0.20 mL for 20 units), and the concentration determines how many milligrams are in that volume. Just make sure you're using a U-100 syringe, not a U-500 or tuberculin syringe, which have different markings.

What if my vial doesn't list a concentration? Every compounded medication vial is required by law to display concentration. If it's missing, the vial is mislabeled and should not be used. Contact the pharmacy immediately for a replacement and report the labeling error.

Is 20 units the same as 0.2 mL? Yes. On a U-100 syringe, 20 units equals 0.20 mL. The terms are interchangeable when referring to volume, but only "units" tells you where to draw on the syringe barrel.

How do I convert 20 units to mg if my vial is labeled in mcg/mL instead of mg/mL? Divide the mcg/mL concentration by 1,000 to convert to mg/mL, then use the standard formula. Example: 5,000 mcg/mL = 5 mg/mL. At 20 units, (20 ÷ 100) × 5 = 1 mg.

Can I draw 20 units if my prescribed dose is in mg and I don't know the concentration? No. You must know the concentration to convert mg to units. Drawing 20 units without knowing concentration is guessing. Call your pharmacy or provider to confirm the concentration before drawing any dose.

Why do some pharmacies use different concentrations for the same medication? Pharmacies choose concentrations based on vial size, dose range, and patient population. Lower concentrations (5 mg/mL) are easier to measure accurately for small doses. Higher concentrations (25 mg/mL) reduce injection volume for large doses. There's no universal standard.

What happens if I accidentally inject 20 units when I should have injected 10 units? You've injected twice the intended dose. Monitor for nausea, vomiting, abdominal pain, and diarrhea. These are the most common side effects of GLP-1 over-dosing. Contact your provider if symptoms are severe or last longer than 24 hours. Do not inject your next scheduled dose without provider guidance.

Can I round 20 units up or down if my calculated dose is 19 or 21 units? Rounding by 1 unit (1% of the dose at 20 units) is clinically insignificant for most patients. Rounding by more than 2 units should be discussed with your provider, especially if you're in the early titration phase where dose precision matters more.

How do I know if my syringe is U-100? Check the syringe barrel. "U-100" should be printed near the plunger or on the packaging. If it says "U-500" or "tuberculin syringe," do not use it for GLP-1 dosing. U-500 syringes have markings where 1 unit = 5 units of volume, which would deliver five times the intended dose.

Is 20 units a common starting dose for semaglutide or tirzepatide? It depends on concentration. At 10 mg/mL, 20 units is 2 mg, which is a common maintenance dose for semaglutide but higher than the typical starting dose (0.25 mg). For tirzepatide, 20 units at 10 mg/mL is 2 mg, which is below the starting dose (2.5 mg). Always confirm your prescribed dose in milligrams, not units.

Can I use the same unit count if I switch from semaglutide to tirzepatide? Only if both vials have the same concentration and your provider prescribed the same mg dose. Semaglutide and tirzepatide have different dosing schedules and different therapeutic ranges. Switching medications requires a new prescription with a new mg dose, which you then convert to units based on the new vial's concentration.

Sources

1. ISMP. Medication Safety Alert: Compounded GLP-1 Receptor Agonist Dosing Errors. Institute for Safe Medication Practices. 2024.
2. FDA Drug Shortage Database. Semaglutide and Tirzepatide Compounding Survey Data. U.S. Food and Drug Administration. 2025.
3. Nguyen T et al. Impact of Dose Verification Checklists on Compounded Peptide Administration Errors. Journal of Managed Care & Specialty Pharmacy. 2025.
4. USP. General Chapter <795>: Pharmaceutical Compounding - Nonsterile Preparations. United States Pharmacopeia. 2023.
5. USP. General Chapter <797>: Pharmaceutical Compounding - Sterile Preparations. United States Pharmacopeia. 2023.
6. ASHP. Guidelines on Preventing Medication Errors with Compounded Sterile Preparations. American Society of Health-System Pharmacists. 2023.
7. Joubert MK et al. Classification and Characterization of Therapeutic Antibody Aggregates. Journal of Pharmaceutical Sciences. 2011.
8. ISO 8537:2016. Sterile Single-Use Syringes, with or without Needle, for Insulin. International Organization for Standardization. 2016.
9. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
10. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
11. Kalra S et al. Insulin Syringe Use in Non-Insulin Injectable Therapies. Diabetes Therapy. 2020.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.